Rigel Pharmaceuticals/ US7665597024 /
2024-09-20 9:59:48 PM | Chg. +0.08 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
13.77USD | +0.58% | 3,831 Turnover: 53,191.20 |
-Bid Size: - | -Ask Size: - | 14.06 | 13.60 |
GlobeNewswire
2020-06-24
Cytovia Therapeutics, Inc Adds Two Industry Leaders to Its Board of Directors
GlobeNewswire
2019-11-07
Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights a...
GlobeNewswire
2019-09-27
Global Immune Thrombocytopenia (ITP) Market Expected to Reach $2.27 Billion in 2023, Growing at a CA...
GlobeNewswire
2019-01-24
Market Trends Toward New Normal in SeaWorld Entertainment, Rigel Pharmaceuticals, Guidewire Software...
GlobeNewswire
2018-12-03
New Research Coverage Highlights Weight Watchers International, Rudolph Technologies, Lowe's Compani...
GlobeNewswire
2018-08-31
New Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, H...
GlobeNewswire
2018-08-10
Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fib...
GlobeNewswire
2018-07-27
Recent Analysis Shows Synopsys, Rigel Pharmaceuticals, Fate Therapeutics, Philip Morris Internationa...
GlobeNewswire
2018-02-21
New Research: Key Drivers of Growth for SpartanNash, Nustar GP, Hornbeck Offshore Services, TiVo, El...
GlobeNewswire
2017-12-04
Detailed Research: Economic Perspectives on TiVo, Eli Lilly, Rigel Pharmaceuticals, SpartanNash, Nus...
GlobeNewswire
2017-11-06
Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell V...
GlobeNewswire
2017-09-05
Aclaris Therapeutics Announces Issuance of Two U.S. Patents Covering JAK Inhibitors for Treating Hai...
GlobeNewswire
2017-05-05
Aclaris Therapeutics Completes Phase 1 Clinical Trial of ATI-50001 for the Treatment of Alopecia Uni...
GlobeNewswire
2017-04-04
Syndax Pharmaceuticals Adds Biopharmaceutical Industry Leader Keith A. Katkin to Board of Directors
GlobeNewswire
2017-03-15
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corpor...
GlobeNewswire
2016-12-07
Aclaris Therapeutics Initiates Phase 1 Clinical Trial for ATI-50001, an Investigational JAK Inhibito...
GlobeNewswire
2009-07-30
BB BIOTECH: Positive development thanks to Genentech and Vertex
participations